SCHEMBL18847754

SCHEMBL18847754

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4nc5ccccc5c5c6c(ccc45)C(c4ccccc4)(c4ccccc4)c4ccccc4-6)cc3)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.43
KMT2A Q03164 5/20 0.43
ATM Q13315 2/20 0.43
NUDT1 P36639 3/20 0.34
MAPT P10636 3/20 0.34
GAA P10253 2/20 0.34
ABCG2 Q9UNQ0 1/20 0.33
ADORA2A P29274 1/20 0.33
LMNA P02545 3/20 0.33
L3MBTL1 Q9Y468 2/20 0.32
ALDH1A1 P00352 1/20 0.32
RAD52 P43351 1/20 0.32
KDM4E B2RXH2 2/20 0.32
OPRK1 P41145 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
PDE5A O76074 1/20 0.32
DHODH Q02127 1/20 0.32
TDP1 Q9NUW8 1/20 0.31
WHR1 P49842 1/20 0.31
NPC1 O15118 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18847919 0.99 MEN1 (0.42) MEN1KMT2AATMNUDT1MAPT
SCHEMBL18847799 0.96 MEN1 (0.47) MEN1KMT2AATMNUDT1MAPT
SCHEMBL18847835 0.96 MEN1 (0.47) MEN1KMT2AATMNUDT1MAPT
SCHEMBL18847767 0.95 MEN1 (0.46) MEN1KMT2AATMNUDT1MAPT
SCHEMBL18847825 0.95 MEN1 (0.46) MEN1KMT2AATMNUDT1MAPT
SCHEMBL18847796 0.95 MEN1 (0.46) MEN1KMT2AATMNUDT1MAPT
SCHEMBL18847764 0.95 MEN1 (0.46) MEN1KMT2AATMNUDT1MAPT
SCHEMBL18847800 0.95 MEN1 (0.46) MEN1KMT2AATMNUDT1MAPT
SCHEMBL18847969 0.95 MEN1 (0.46) MEN1KMT2AATMNUDT1MAPT
SCHEMBL18847922 0.95 MEN1 (0.41) MEN1KMT2AATMNUDT1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10446765-B2 Heterocyclic compound and organic light emitting element using same HEESUNG MATERIAL LTD. (KR) 2019-10-15 US disclosed
US-20170133602-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME HEESUNG MATERIAL LTD. (KR) 2017-05-11 US disclosed
US-20170133602-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME HEESUNG MATERIAL LTD. (KR) 2017-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170133602-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME CRY1, CRY2, PER2 MEN1 1034/4885KMT2A 579/4885ATM 3417/4885
US-10446765-B2 Heterocyclic compound and organic light emitting element using same CRY1, CRY2, PER2 MEN1 1034/4885KMT2A 579/4885ATM 3417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.